SCHEMBL13304833

SCHEMBL13304833

Bc1cnn2c(NCc3ccc(S(N)(=O)=O)cc3)cc(C3CCN(C(=O)OCc4ccccc4)CC3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 6/20 0.52
▸ CA1 P00915 5/20 0.52
▸ CA7 P43166 5/20 0.52
▸ CA9 Q16790 4/20 0.52
▸ GSK3B P49841 3/20 0.42
▸ ENPP2 Q13822 3/20 0.42
▸ TRPC3 Q13507 2/20 0.42
▸ TRPC7 Q9HCX4 2/20 0.42
▸ CYP2C9 P11712 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ GRIN2B Q13224 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ F13A1 P00488 1/20 0.39
▸ TGM2 P21980 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953550 0.92 GSK3B (0.52) CA2CA1CA7CA9GSK3B
SCHEMBL14043203 0.89 TRPC3 (0.44) GSK3BENPP2TRPC3TRPC7CYP2C9
SCHEMBL13305198 0.86 GSK3B (0.56) GSK3BTRPC3TRPC7CYP2C9CYP3A4
SCHEMBL13118082 0.85 GSK3B (0.51) CA2CA1CA7CA9GSK3B
SCHEMBL13305170 0.84 TRPC3 (0.43) GSK3BENPP2TRPC3TRPC7CYP2C9
SCHEMBL12953650 0.82 GSK3B (0.54) GSK3BTRPC3TRPC7CYP2C9RAB9A
SCHEMBL13305093 0.82 TRPC3 (0.41) GSK3BENPP2TRPC3TRPC7CYP2C9
SCHEMBL13305680 0.80 GSK3B (0.55) CA2CA1CA9GSK3B
SCHEMBL12953476 0.80 GSK3B (0.52) GSK3BTRPC3TRPC7CYP2C9CYP3A4
SCHEMBL12953454 0.79 CDK2 (0.54) GSK3BTRPC3TRPC7CYP2C9GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback